Answers are grounded in this paper and cite their sources.
Perspective review highlights advances in porous scaffolds and conducting polymers for in vitro extracellular matrix modeling, indicating alternatives to animal testing in preclinical drug evaluation.
Animal studies have long been considered the gold standard for studying disease and analysing drug efficacy in preclinical research. However, the use of animals for studying human systems is now more commonly regarded as ethically questionable, expensive and a poor predictor of human cell response, leading to the widespread movement towards the replacement, reduction and refinement (3Rs) of animal testing in research. This perspective provides an overview of the benefit of moving away from animal models to more sustainable three dimensional (3D) in vitro culture systems and introduces current materials for modelling the extracellular matrix. We will focus primarily on the application of porous scaffolds as we progress from materials that simply support cell hosting to materials such as conducting polymers that are also able to monitor the health of cells grown on their surface.
No takes yet. Share an insight, caveat, or question.
Sumner et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: